2026 ICD-10-CM Diagnosis Code C7A.1Malignant poorly differentiated neuroendocrine tumors
ICD-10-CM Codes›C00–D49›C7A›C7A
- Billable — Valid for Submission
- Chronic Condition
C7A.1 is a billable ICD-10-CM diagnosis code for malignant poorly differentiated neuroendocrine tumors. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 826 through 830, 843 through 845. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Malignant neuroendocrine tumors.
Code Identity
Code Classification
Tabular List NotesGuidance
Coding notes and annotation back-references applicable to this code.
Inclusion Terms
- Malignant poorly differentiated neuroendocrine tumor NOS
- Malignant poorly differentiated neuroendocrine carcinoma, any site
- High grade neuroendocrine carcinoma, any site
These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of "other specified" codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.
Index to Diseases and InjuriesGuidance
Alphabetical index entries that point to this code.
- Carcinoma (malignant) - See Also: Neoplasm, by site, malignant;
- neuroendocrine - See Also: Tumor, neuroendocrine;
- high grade, any site - C7A.1
- poorly differentiated, any site - C7A.1
- Tumor - See Also: Neoplasm, unspecified behavior, by site;
- neuroendocrine - D3A.8
- malignant poorly differentiated - C7A.1
External Cause of Injuries IndexGuidance
References for this code in the External Cause of Injuries Index.
- Carcinoma(malignant)
- neuroendocrine
- high grade, any site
- Carcinoma(malignant)
- neuroendocrine
- poorly differentiated, any site
- Tumor
- neuroendocrine
- malignant poorly differentiated
Clinical ClassificationClinical
AHRQ’s CCSR groups this code into broader clinical categories.
Patient EducationClinical
Cancer
Cancer is not just one disease but many diseases. Cancer begins in your cells, which are the building blocks of your body. Usually, your body forms new cells as needed, replacing old cells that die. Sometimes this process goes wrong. New cells grow even when you don't need them, and old cells don't die when they should.
The full article covers:
- What is cancer?
- What are the types of cancer?
- How does cancer develop?
- What are the symptoms of cancer?
- How is cancer diagnosed?
- What are the treatments for cancer?
- Can cancer be prevented?
Read the full article at MedlinePlus
Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.
Convert C7A.1 to ICD-9-CMHistory
The closest ICD-9-CM equivalents under the General Equivalence Mappings.
Code HistoryHistory
Questions About C7A.1Overview
Is C7A.1 (Malignant neuroendocrine tumors) a billable code?
Yes. This is a billable ICD-10-CM code, specific enough to report malignant poorly differentiated neuroendocrine tumors on HIPAA-covered claims from October 1, 2025 through September 30, 2026.
What MS-DRG does C7A.1 group to?
When malignant poorly differentiated neuroendocrine tumors is the principal diagnosis on an inpatient stay, it groups to MS-DRG 826, 827, 828, 829, 830, 843, 844, 845, with relative weights from 0.8516 to 4.6778 depending on complications. Higher weights mean higher Medicare reimbursement.
What is the ICD-9 equivalent of C7A.1?
Under the General Equivalence Mappings, malignant poorly differentiated neuroendocrine tumors converts to ICD-9-CM 209.30 (malig neuroendo ca NOS). The mapping is approximate, so confirm the match fits the documentation.
Footnotes
[1] Chronic - a chronic condition code indicates a condition lasting 12 months or longer and its effect on the patient based on one or both of the following criteria:
- The condition results in the need for ongoing intervention with medical products,treatment, services, and special equipment
- The condition places limitations on self-care, independent living, and social interactions.
